We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Detects Tumor Markers Using Laser-Stimulated Fluorescence

By LabMedica International staff writers
Posted on 09 Apr 2014
Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously involving highly specific proteins.

An increased concentration in the blood provides one indication of the disease for physicians, but it has been quite expensive in time and effort to detect the markers thus far and to be able to detect a single specific one, scientists must first separate and purify the blood in several steps and then isolate the marker.

Scientists at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA (Mannheim, Germany) have developed a one-step analysis to detect tumor biomarkers. More...
The difficulty in detecting specific molecules in the blood or urine lies in the enormous number of substances that are mixed in the sample. They cause a high level of background noise that masks the desired signal and the signal from the protein being searched for can no longer be distinguished.

To improve the signal to noise ratio, the scientists used magnetic beads, which are particles only a few micrometers in size that have a magnetic core. If a magnet is positioned externally on the test tube, the beads can be arrested or steered. This technique is already in use. To isolate molecules from a solution like blood, the surface of the beads with were coated with specialized antibodies. The proteins that are being searched for wind past the beads, and the antibodies attach to them. If the magnet is held to the outside of the test tube, the beads together with the desired proteins stick to the interior surface of the tube, while the rest of the solution can be easily removed.

Additional means were developed with the samples exposed to the coated beads, but also to additional antibodies that have fluorescent markers bound to them. These antibodies attach themselves to the proteins being searched for and cause them to fluoresce. The optical signal is very weak though, and would normally disappear in the background noise. When using an alternating magnetic field, the magnetic beads flock together in rhythm, and the fluorescent markers bound to the surfaces emit their light in synchrony and radiate considerably more brightly than any given bead by itself. The advantage of this visualization technique is that the optical signal provides immediate insight about whether a tumor marker protein is present in the blood. The analysis equipment was presented at the Analytica international trade fair held April 1–4, 2014, in Munich (Germany).

Related Links:

Fraunhofer Institute for Manufacturing Engineering and Automation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
HPV Test
Allplex HPV28 Detection
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.